Friday 30 September 2016

---

Sahajanand Medical Technologies (SMT) is to create 50 jobs over five years as it establishes its European headquarters, which will have a state-of-the-art research, development and innovation centre, in Galway. SMT is the largest developer and manufacturer of minimally invasive coronary stent systems in India and supplies to around 60 countries in Europe, Asia, MENA and Latin America. It has received numerous awards for its breakthrough innovations and quality that have led to thinner and flexible DES with good long term clinical results. “We were pioneers among Indian medical device companies to identify tremendous value in investing in research and development. Our core strength lies in our ability to excel in developing technologically complex products through focused teams. With this centre, we hope to tap into the excellent talent pool available in Galway to make further enhancements in existing products and to develop new and innovative products,” said Gaurav Goel of SMT. IDA Ireland’s CEO Martin Shanahan said he was delighted to welcome SMT to Galway. “This is an important win for the west region in line with our strategy to promote investment in regional locations. It will act as a valuable reference seller for us in attracting other companies in the medical technologies sector to the region. I wish Gaurav and his team here in Galway every success,” he added.